Last reviewed · How we verify
Pregabalin; Dexamethasone
Pregabalin; Dexamethasone is a Small molecule drug developed by Glostrup University Hospital, Copenhagen. It is currently FDA-approved.
Pregabalin and Dexamethasone, marketed by Glostrup University Hospital, Copenhagen, hold a significant position in their therapeutic areas with a key composition patent expiring in 2028. The combination's key strength lies in its well-established mechanism and primary indication, which provides a robust foundation for continued use and revenue generation. The primary risk is the potential increase in competition post-patent expiry in 2028, which could impact market share and revenue.
At a glance
| Generic name | Pregabalin; Dexamethasone |
|---|---|
| Sponsor | Glostrup University Hospital, Copenhagen |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain (NA)
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study (PHASE4)
- Pre vs Post Block in Total Knee Arthroplasty (TKA) (PHASE4)
- Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair (PHASE4)
- Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pregabalin; Dexamethasone CI brief — competitive landscape report
- Pregabalin; Dexamethasone updates RSS · CI watch RSS
- Glostrup University Hospital, Copenhagen portfolio CI
Frequently asked questions about Pregabalin; Dexamethasone
What is Pregabalin; Dexamethasone?
Who makes Pregabalin; Dexamethasone?
What development phase is Pregabalin; Dexamethasone in?
Related
- Manufacturer: Glostrup University Hospital, Copenhagen — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing